Decrease in articular hypoxia and synovial blood flow at early time points following infliximab and etanercept treatment in rheumatoid arthritis
<strong>Objectives:</strong> An important feature of rheumatoid arthritis (RA) is hypoxia-driven synovial angiogenesis, but the relationship between change in vascularity, as measured by power Doppler ultrasound (PDUS), and oxygen tensions is unaddressed. <strong>Methods:</stro...
Hauptverfasser: | Fisher, B, Donatien, P, Filer, A, Winlove, P, McInnes, I, Buckley, C, Taylor, P |
---|---|
Format: | Journal article |
Veröffentlicht: |
Clinical and Experimental Rheumatology Sas
2016
|
Ähnliche Einträge
-
Synovial hypoxia as a cause of tendon rupture in rheumatoid arthritis.
von: Sivakumar, B, et al.
Veröffentlicht: (2008) -
The effectiveness of infliximab and etanercept for the treatment of rheumatoid arthritis: A systematic review and economic evaluation
von: Jobanputra, P, et al.
Veröffentlicht: (2002) -
The effectiveness of infliximab and etanercept for the treatment of rheumatoid arthritis: a systematic review and economic evaluation.
von: Jobanputra, P, et al.
Veröffentlicht: (2002) -
The effectiveness of infliximab and etanercept for the treatment of rheumatoid arthritis: a systematic review and economic evaluation
von: P. Jobanputra, et al.
Veröffentlicht: (2002-01-01) -
Plasma levels of the n-3 polyunsaturated fatty acid eicosapentaenoic acid are associated with anti-TNF responsiveness in rheumatoid arthritis, and inhibit the etanercept driven rise in Th17 cell differentiation in vitro
von: Taylor, P, et al.
Veröffentlicht: (2017)